Home » Topics » Regulatory

Regulatory
RSS

Alferon N injection undergoes phase III in HCV

July 19, 1996

SmithKline Beecham's new Havrix formulation receives Canadian approval

July 19, 1996

Trial results described for methylphenidate in head injury patients

July 19, 1996

Athena Neurosciences acquires worldwide rights to new formulation of Carbatrol

July 19, 1996

Pharmos receives grant to develop loteprednol/tobramycin combination product

July 19, 1996

Zadaxin/zidovudine/interferon alpha combination enhances immune system

July 19, 1996

Triple anti-HIV therapy shows positive results

July 19, 1996

Protease inhibitor plus Epivir/Retrovir cocktail shows positive anti-HIV results

July 19, 1996

Taro's clobetasol propionate approved by FDA

July 19, 1996

Clinical trials begin for chronic hepatitis C agent, Alferon N Injection

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...